sec filing
IN
NASDAQ · INMB
INmune Bio, Inc.
Healthcare · Biotechnology
$2.18
Up+$0.16 (+7.11%)
Updated Sep 18, 2026, 6:27 PM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 56.63M
- P/E ratio
- -1.14
- Dividend yield
- 0.00%
- 52-week range
- $1.09 – $2.60
- Volume
- 421.67K
- Avg. volume
- 455.95K
Price performance
INMB price history
1M range · 20 trading sessions · Daily adjusted prices
INMB closed at $2.18 after 20 trading sessions, up 0.93% for the selected period.
- Last close
- $2.18
- Period change
- +0.93%
- Period low
- $2.05
- Period high
- $2.51
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $2.065 | $2.215 | $2.06 | $2.18 | 421.67K |
| Sep 16, 2026 | $2.22 | $2.2384 | $1.965 | $2.05 | 923.29K |
| Sep 15, 2026 | $2.35 | $2.35 | $2.21 | $2.26 | 350.25K |
| Sep 14, 2026 | $2.23 | $2.35 | $2.18 | $2.33 | 370.1K |
| Sep 11, 2026 | $2.35 | $2.37 | $2.21 | $2.22 | 228.38K |
| Sep 10, 2026 | $2.43 | $2.46 | $2.29 | $2.31 | 385.85K |
| Sep 9, 2026 | $2.545 | $2.575 | $2.45 | $2.46 | 239.84K |
| Sep 8, 2026 | $2.44 | $2.60 | $2.41 | $2.51 | 494.31K |
| Sep 4, 2026 | $2.27 | $2.4499 | $2.22 | $2.44 | 323.96K |
| Sep 3, 2026 | $2.37 | $2.409 | $2.27 | $2.27 | 149.81K |
| Sep 2, 2026 | $2.25 | $2.38 | $2.2445 | $2.35 | 171.01K |
| Sep 1, 2026 | $2.26 | $2.27 | $2.2128 | $2.24 | 206.15K |
| Aug 31, 2026 | $2.32 | $2.33 | $2.21 | $2.30 | 295.26K |
| Aug 28, 2026 | $2.40 | $2.45 | $2.3009 | $2.33 | 215.13K |
| Aug 27, 2026 | $2.47 | $2.49 | $2.40 | $2.40 | 323.51K |
| Aug 26, 2026 | $2.40 | $2.499 | $2.3997 | $2.445 | 419.65K |
| Aug 25, 2026 | $2.40 | $2.44 | $2.35 | $2.43 | 264.8K |
| Aug 24, 2026 | $2.30 | $2.48 | $2.24 | $2.36 | 501.66K |
| Aug 21, 2026 | $2.22 | $2.341 | $2.19 | $2.32 | 520.14K |
| Aug 20, 2026 | $2.20 | $2.24 | $2.145 | $2.16 | 393.67K |
Latest INMB news
The latest Smart Investors Daily articles mentioning INMB.
Stock researchResearch & News · Competitors
Loading stock research…

